Navigation Links
Mixed in Medical Technology

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

... is showing that as stand-alone products or mixed with other substances, these drinks need to be ... on kids and what happens when energy drinks are mixed with alcohol and other stimulants. SUNY Youth ... recent work explores the consumption of alcohol mixed with energy drinks, and the association of this ...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

... the acute treatment of schizophrenia or manic or mixed episodes associated with bipolar I disorder in ... safety. For the proposed indication for manic or mixed episodes associated with bipolar I disorder, the ... (aged 13-17 years) with acute manic or mixed episodes associated with bipolar I disorder. ...

New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management

... calcium (5 mg, 10 mg, 20 mg) in patients with mixed dyslipidemia ORLANDO, Fla., March 29 ... is often needed in certain patients with mixed dyslipidemia to help reach targets for all three ... 12-week, Phase III study of 760 patients with mixed dyslipidemia. Patients included in the study had ...

Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia

... both patients with very high triglycerides and mixed dyslipidemia and includes normal weight, ... of DCCR to treat both very high triglycerides and mixed dyslipidemia, delivering a competitive profile of ... elevations in LDL-cholesterol. About mixed Dyslipidemia The prevalence ...

Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia

... of obesity and its consequences, one of which is mixed dyslipidemia. Patients with this type of ... to understanding the ability of MBX-8025 to treat mixed dyslipidemia, as well as providing preliminary ... high triglyceride levels -- known collectively as mixed dyslipidemia. Though some drugs have marked ...

Abbott's Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes

... data from a sub-group analysis of patients with mixed dyslipidemia and type 2 diabetes that were ... living with diabetes. These patients often have mixed dyslipidemia, a complex combination of ... aggressive treatment of lipids in patients with mixed dyslipidemia and type 2 diabetes," said Peter H. ...

Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids

... were identified in this study. "Patients with mixed dyslipidemia may need treatment options that ... 12-week, Phase III study of 1,445 patients with mixed dyslipidemia. Patients included in the study had ... and rosuvastatin) in 2,698 patients with mixed dyslipidemia. The clinical program also ...

BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer

... treatment of uterine carcinosarcoma or malignant mixed mullerian tumors. This multi-center, ... uterine carcinosarcomas. The identification of mixed mullerian tumors of the uterus as a target for ... was particularly intense in uterine mixed mullerian tumors, a cancer for which there is no ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)

... for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with ... the acute and maintenance treatment of manic and mixed episodes associated with Bipolar I Disorder with ... diagnosis of Bipolar I Disorder, manic or mixed episodes, with or without psychotic features. ...

Pistachios Offer Protective Benefits Against Heart Disease, Type II Diabetes and Obesity

... to receive one of three diet interventions: 1) 2-1/2 ounces or 1/2 cup of mixed nuts (including pistachios); 2) 1-1/3 ounces or 1/4 cup of mixed nuts and half portion of muffin; or 3) full portion of muffin. Each snack ...

New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds

... immediate polymerization, or 'gluing,' of stem cells in fibrinogen when mixed with thrombin," said Dr. Falanga. "Both fibrinogen and thrombin are naturally occurring substances in blood which, when mixed to form fibrin, are normally involved in the formation of a clot. In this ...

Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder

... a mix of the two," says Dr. Frye. "Our data would suggest that people with mixed depression may need to stay away from antidepressants and work with their ... research is encouraged to better understand the best treatment for these mixed presentations. Other authors for this article include: Gerhard ...

NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis

... versus naproxen). CIs are obtained from pair-wise contrasts from a mixed model meta-analysis with study, treatment and baseline as fixed effects, ... P values for categorized changes from baseline are based on the same mixed model meta-analysis as above performed on log odds ratios from logistic ...

Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL

... controlled, 12-week Phase III studies, totaling 2,698 patients with mixed dyslipidemia. Patients included in the studies had multiple lipid ... TriLipix in combination with rosuvastatin in over 1,400 patients with mixed dyslipidemia, are planned for presentation at scientific forums throughout ...

New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease

... of various lipid disorders including primary hypercholesterolemia, mixed dyslipidemia and isolated hypertriglyceridemia, available in a 5-, 10-, ... heart attacks, or strokes. For patients with hypercholesterolemia and mixed dyslipidemia, the usual recommended starting dose of CRESTOR is 10 mg. ...

New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure

... of various lipid disorders including primary hypercholesterolemia, mixed dyslipidemia and isolated hypertriglyceridemia, available in a 5-, 10-, ... heart attacks, or strokes. For patients with hypercholesterolemia and mixed dyslipidemia, the usual recommended starting dose of CRESTOR is 10 mg. ...

Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder

... in children aged 7 to 17 years, diagnosed with bipolar I disorder, mixed or manic, based on standardized criteria. Specifically, at the end of an ... in children aged 7 to 17 years, diagnosed with bipolar I disorder, mixed or manic. Cincinnati Children's Hospital Medical Center, one of the ...

Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination

... of CRESTOR and ABT-335 may be an important option to help patients with mixed dyslipidemia achieve their treatment goals." ABT-335 and CRESTOR are both ... heart attacks, or strokes. For patients with hypercholesterolemia and mixed dyslipidemia, the usual recommended starting dose of CRESTOR is 10 mg. ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... Advisory Committee voted unanimously in favor of SAPHRIS(R) (asenapine) sublingual tablets as effective and safe for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults and in favor of use in acute treatment of schizophrenia in adults. If approved by FDA, SAPHRIS ...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

... MD, FAAD, assistant clinical professor of dermatology at the University of California at Davis in Sacramento, reviewed studies that demonstrate mixed results when examining whether or not estrogen improves the appearance of the skin and why patients should opt for tried-and-true cosmetic therapies ...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... and then monthly for five months for a total of up to eight injections. The patient's dendritic cells were obtained from their peripheral blood and mixed with a cell culture of the patient's own melanoma cells that had been self-renewing and proliferating in the laboratory. The patient-specific vaccine ...

Reliv International's GlucAffect(TM) Proven Effective in Clinical Study

... The study included 50 overweight individuals who had pre-diabetic glucose levels prior to the study. Subjects taking GlucAffect, a powdered product mixed with water or other liquids, lowered their fasting blood glucose by an average of 30 percent and they lost an average of 16 pounds. Subjects in the ...

Study Demonstrates Efficacy of Pitavastatin in Elderly Patients

... indicated as adjunctive therapy to diet to reduce elevated triglycerides and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. For more information about KPA, please visit www.kowapharma.com . ...

Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

... was glycemic control, as measured by change from baseline in HbA1C; additional endpoints evaluated included changes in fasting serum glucose, solid mixed meal glucose excursion and body weight. For all doses in this study, statistically significant reductions in all metabolic measures were ...

Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia

... A key secondary endpoint was the change from baseline in CGI-S over the six-week study period. Efficacy data were statistically analyzed using a mixed model for repeated measures. Multiple safety assessments were done, including vital signs, weight, ECGs, movement disorder scales (SAS, BAS, AIMS), ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... as maintenance therapy in patients who met DSM-IV criteria for Bipolar I Disorder who were stable on medications or experiencing an acute manic or mixed episode. In the first phase of the study, 303 patients were stabilized on open-label RISPERDAL(R) CONSTA(R) for 26 weeks. In the double-blind phase, ...

Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

... reduction in a 90-patient Phase 2b trial of DCCR in dyslipidemic patients. The study encompassed both patients with very high triglycerides and mixed dyslipidemia and included normal weight, overweight and obese patients presenting with or without hypertension. The randomized, double-blind ...

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

... Fanapt(TM) to placebo and active control in patients with schizophrenia, as well as safety data from more than 3,000 patients. Fanapt(TM) is a mixed dopamine D2 / serotonin 5HT2A receptor antagonist, and belongs to the class of atypical antipsychotics. "The approval of Fanapt(TM) marks a new ...

Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses

... of the Governor's Award of Excellence. This facility opened its doors in 1977. For Taylor and the surrounding communities, extensive healthcare mixed with outstanding customer service has been the standard for over 30 years. This 209-bed hospital provides specialty services to all Oakwood Heritage ...

CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis

... to diet to reduce elevated Total-C, LDL-C, ApoB, non-HDL-C, and TG levels and to increase HDL-C in adult patients with primary hyperlipidemia and mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis as part of a treatment strategy to lower ...

CRESTOR(R) Reduced Risk of Blood Clots in the Veins

... to diet to reduce elevated Total-C, LDL-C, ApoB, non-HDL-C, and TG levels and to increase HDL-C in adult patients with primary hyperlipidemia and mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis as part of a treatment strategy to lower ...

Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain

... STUDY CONFIRMS EFFICACY IN VALIDATED ENDPOINTS; mixed RESULTS IN EXPLORATORY ENDPOINTS COMPANY TO HOST CONFERENCE CALL AND WEBCAST THURSDAY, MARCH 26TH AT 8:00AM ET / 5:00AM PT SAN DIEGO, ...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

... DENVER, March 18 /PRNewswire-USNewswire/ -- New data evaluating the impact of screening on mortality provides mixed messages on the value of prostate cancer screening. The Prostate Conditions Education Council (PCEC), a national organization committed to men's ...

Vermillion Presents Critical Data From Its OVA1 Clinical Trial

... undergoes a gynecological examination with radiological and clinical testing prior to surgical intervention. The 27 sites were demographically mixed to include, for example, large and small medical centers (universities/community hospitals), small gynecology/obstetrics groups, gynecology/oncology ...

Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain

... pain. Researchers looked at many factors including: which steroids were given, the amount of steroid used, and whether or not a local anesthetic was mixed with the steroid. Epidural steroid injections (ESI) are minimally invasive procedures used to treat pain in the neck, arms, back and legs ...

Chemoembolization Improving as Liver Cancer Treatment

... it more effective and promising as a cure in some cases. Improvements include beads that absorb the chemotherapeutic agent (rather than just being mixed with it), and then release the drug once in the body, as well as modifications to uniformity and size of the beads themselves so that they can more ...

U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder

... letter for SAPHRIS(TM) (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy. The action letter includes proposed labeling for both indications and a ...

FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

... Safety information for Zyprexa Zyprexa oral is indicated in the United States for the short- and long- term treatment of schizophrenia, acute mixed and manic episodes of bipolar I disorder, and maintenance treatment of bipolar disorder. Olanzapine is not approved for the treatment of ...

Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows

... reduction in the rate of heart attack, stroke, bypass surgery, or cardiovascular death was 44%. MedPage Today poll participants registered mixed views as to the best preventive cardiovascular strategy, with most alternating between lifestyle changes and drug therapy. Among the ...

Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects

... other Asian markets; SAPHRIS(TM)** (asenapine), a novel psychopharmacologic agent (under U.S. review for schizophrenia and acute manic or mixed episodes associated with bipolar I disorder); pivotal relapse-prevention data were presented showing that only 12 percent of patients receiving ...
Other Contents
(Date:9/2/2014)... digital distribution of media will have lower carbon ... when file sizes are large. , That,s the ... Journal of Industrial Ecology that looked at ... as PlayStation3. Researchers found that Blu-ray Discs delivered ... than game files downloaded over broadband Internet. For ...
(Date:9/2/2014)... a new study that could ultimately lead to many ... Scripps Research Institute (TSRI) have adapted a chemical approach ... molecules that can treat a form of muscular dystrophy. ... and a disease-causing defect as a catalyst to synthesize ... Matthew Disney.,"Because the treatment is synthesized only in diseased ...
(Date:9/2/2014)... with the participation of the University of Granada has ... place in the Iberian Peninsula around the mid Holocene ... dust coming from the Sahara increased. The data came ... Alpine lake in Sierra Nevada (Granada) , This study, ... based on the sedimentation of atmospheric dust from the ...
Breaking Biology News(10 mins):Scripps Florida scientists make diseased cells synthesize their own drug 2Scientists obtain new data on the weather 10,000 years ago from sediments of a lake in Sierra Nevada 2
(Date:9/2/2014)... Welcome to Arthritis Awareness Month . ... living with the disease, The Arthritis Society is kicking ... featuring well-known Canadians from different walks of life telling ... Robertson , veteran news anchor ,      ...      Amy Cotton , two-time Olympic wrestler ...
(Date:9/2/2014)... overdoses has become an increasing concern to health officials ... York City Department of Health and Mental Hygiene, the ... nearly triple the number of such deaths in 2000. ... dramatic rise in nonmedical prescription opioid (PO) use among ... use among youth who transitioned from POs to heroin. ...
(Date:9/2/2014)... have made it clear that a mother,s eating habits ... a profound impact on her offspring and their propensity ... now, the mechanisms behind this phenomenon were unclear. According ... of The FASEB Journal F , scientists ... a mother,s diet and an offspring,s risk of future ...
(Date:9/2/2014)... September 02, 2014 HMP Communications ... education, is proud to announce the acquisition of ... center designed for healthcare professionals who integrate diet and ... comprehensive access to:, , Late-breaking news ... Dedicated topic centers for diabetes, oncology, renal disease, wound ...
(Date:9/2/2014)... from cancer surgery may be influenced by more ... Family conflicts and other non-medical problems may raise ... study has found. Addressing such quality-of-life issues before ... recoveries and save health care dollars, the research ... patients, and found that patients with a poor ...
Breaking Medicine News(10 mins):Health News:‘Voices of Arthritis’ Launches Awareness Month 2Health News:‘Voices of Arthritis’ Launches Awareness Month 3Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2
Other TagsOther Tags